After years in the clinical lab space,  inspired by the desire to create something meaningful and useful to the clinical lab industry Kris Franklin began looking for ways to simplify sample collection and open up a greater array of blood diagnostics to the average reference lab. Dissatisfied by the clinical utility of urine toxicology and the difficulty of venous blood collection, he set out to find a way to simplify the collection process and expand diagnostic testing. In November of 2014, he met with Dr. Hooper over coffee to understand the fundamentals of small volume blood testing and how he applied a simplified collection technique to assist transplant patients taking immunosuppressants. From that coffee shop meeting the concept was born. The concept was simple, utilize high end tandem mass spectrometry to reduce the amount of blood needed so blood collection could be performed by the patient.

Meetings with lab groups and different teams produced little opportunity to begin the work on a critical piece of technology. In 2015 a relationship was struck with a company and using Shimadzu tandem mass spectrometers the first prototype of a small volume blood application was created. Before product launch could become reality, the equipment was liquidated, but the dream and passion never subsided. As a consultant, Kris Franklin would work in other labs he had established and borrow time on their equipment to push the technology farther and create new ways to create better science. Unique sample prep technology combined with advanced tandem mass spectrometry experience led to scientific leaps forward in what was possible.

In July of 2017 Kris Franklin took on 2 partners. The first being an innovative investor who saw the value in the technology that was being created and the unique opportunity it provided. The other was a renowned pathologist who also recognized the immense value of the technology. As a result of this partnership, CliniCore was formed. A company forged out of tireless persistence and a relentless pursuit of scientific perfection. CliniCore opened with a 12-million-dollar valuation & a mandate to utilize revolutionary science to improve the quality of patient care. With resources in hand, Kris Franklin & his team continually focus on bringing novel diagnostic testing to the clinical arena.